APA

Azevedo O., Gal A., Faria R., Gaspar P., Miltenberger-Miltenyi G., Gago M. F., Dias F., Martins A., Rodrigues J., Reimão P., Pereira O., Simões S., Lopes E., Guimarães M. J., Sousa N. & Cunha D. (20201112). Founder effect of Fabry disease due to p.F113L mutation: Clinical profile of a late-onset phenotype. : Molecular genetics and metabolism.

Chicago

Azevedo Olga, Gal Andreas, Faria Rui, Gaspar Paulo, Miltenberger-Miltenyi Gabriel, Gago Miguel F, Dias Fátima, Martins Alice, Rodrigues Jorge, Reimão Pedro, Pereira Olga, Simões Sónia, Lopes Emilia, Guimarães Maria José, Sousa Nuno and Cunha Damião. 20201112. Founder effect of Fabry disease due to p.F113L mutation: Clinical profile of a late-onset phenotype. : Molecular genetics and metabolism.

Harvard

Azevedo O., Gal A., Faria R., Gaspar P., Miltenberger-Miltenyi G., Gago M. F., Dias F., Martins A., Rodrigues J., Reimão P., Pereira O., Simões S., Lopes E., Guimarães M. J., Sousa N. and Cunha D. (20201112). Founder effect of Fabry disease due to p.F113L mutation: Clinical profile of a late-onset phenotype. : Molecular genetics and metabolism.

MLA

Azevedo Olga, Gal Andreas, Faria Rui, Gaspar Paulo, Miltenberger-Miltenyi Gabriel, Gago Miguel F, Dias Fátima, Martins Alice, Rodrigues Jorge, Reimão Pedro, Pereira Olga, Simões Sónia, Lopes Emilia, Guimarães Maria José, Sousa Nuno and Cunha Damião. Founder effect of Fabry disease due to p.F113L mutation: Clinical profile of a late-onset phenotype. : Molecular genetics and metabolism. 20201112.